909 related articles for article (PubMed ID: 31913745)
1. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
[TBL] [Abstract][Full Text] [Related]
2. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.
Park JS; Lee DH; Lee YS; Oh E; Bae KH; Oh KJ; Kim H; Bae SH
Autophagy; 2020 Jan; 16(1):86-105. PubMed ID: 30907226
[TBL] [Abstract][Full Text] [Related]
3. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.
Deng Z; Lim J; Wang Q; Purtell K; Wu S; Palomo GM; Tan H; Manfredi G; Zhao Y; Peng J; Hu B; Chen S; Yue Z
Autophagy; 2020 May; 16(5):917-931. PubMed ID: 31362587
[TBL] [Abstract][Full Text] [Related]
4. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
[TBL] [Abstract][Full Text] [Related]
5. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
6. PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway.
Lee DH; Park JS; Lee YS; Bae SH
Redox Biol; 2022 Apr; 50():102235. PubMed ID: 35091323
[TBL] [Abstract][Full Text] [Related]
7. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
[TBL] [Abstract][Full Text] [Related]
8. EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation.
Gilardini Montani MS; Santarelli R; Granato M; Gonnella R; Torrisi MR; Faggioni A; Cirone M
Autophagy; 2019 Apr; 15(4):652-667. PubMed ID: 30324853
[TBL] [Abstract][Full Text] [Related]
9. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
[TBL] [Abstract][Full Text] [Related]
11. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
12. Lipotoxicity reduces DDX58/Rig-1 expression and activity leading to impaired autophagy and cell death.
Frietze KK; Brown AM; Das D; Franks RG; Cunningham JL; Hayward M; Nickels JT
Autophagy; 2022 Jan; 18(1):142-160. PubMed ID: 33966599
[TBL] [Abstract][Full Text] [Related]
13. Full-coverage regulations of autophagy by ROS: from induction to maturation.
Zhou J; Li XY; Liu YJ; Feng J; Wu Y; Shen HM; Lu GD
Autophagy; 2022 Jun; 18(6):1240-1255. PubMed ID: 34662529
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity.
Hall BS; Dos Santos SJ; Hsieh LT; Manifava M; Ruf MT; Pluschke G; Ktistakis N; Simmonds RE
Autophagy; 2022 Apr; 18(4):841-859. PubMed ID: 34424124
[TBL] [Abstract][Full Text] [Related]
15. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
Rui YN; Xu Z; Chen Z; Zhang S
Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
17. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
18. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy.
Liu K; Qiu D; Liang X; Huang Y; Wang Y; Jia X; Li K; Zhao J; Du C; Qiu X; Cui J; Xiao Z; Qin Y; Zhang Q
Autophagy; 2022 Apr; 18(4):860-876. PubMed ID: 34382907
[TBL] [Abstract][Full Text] [Related]
19. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.
Mildenberger J; Johansson I; Sergin I; Kjøbli E; Damås JK; Razani B; Flo TH; Bjørkøy G
Autophagy; 2017 Oct; 13(10):1664-1678. PubMed ID: 28820283
[TBL] [Abstract][Full Text] [Related]
20. Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain.
Li J; Tian M; Hua T; Wang H; Yang M; Li W; Zhang X; Yuan H
Autophagy; 2021 Dec; 17(12):4062-4082. PubMed ID: 33834930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]